GW Pharmaceuticals plc and Otsuka Pharmaceutical Co., Ltd. today announce that they have signed a three year extension to their global cannabinoid research collaboration.
This collaboration was originally signed in July 2007 with a three year term, and the collaboration will now extend to the end of June 2013.
Under the research collaboration agreement, GW and Otsuka Pharmaceutical research a range of GW cannabinoids as potential new drug candidates in the field of Central Nervous System (CNS) disorders and oncology.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1815